BioCryst公司的贝罗司他胶囊效果如何

Orladeyo is a plasma kallikrein inhibitor and beroxostat capsules are indicated for the prevention of hereditary angioedema (HAE) in adults and pediatric patients over 12 years of age.

BioCryst Corporation is a biotechnology company. BioCryst designs, optimizes and develops small molecule drugs that block enzymes involved in disease pathogenesis. The company focuses on treating rare diseases. BioCryst uses X-ray scattering technology, molecular structure computer simulations and chemical techniques to focus on the three-dimensional molecular structure and active site characteristics of enzymes that control cell biology. How effective are BioCryst’s berosostat capsules?

Berostat Capsule Orladeyo was safe and well tolerated in both studies. Compared with the placebo group, the most common adverse reaction of Berostat Capsule Orladeyo was gastrointestinal reactions. Usually, the incidence rate is higher in the early stage of treatment with Berostat capsule Orladeyo, and then gradually decreases, and patients can usually relieve themselves.

Patients should note:

DRUG INTERACTIONS: Patients should be informed that Orladeyo Orladeyo capsules may interact with other medications. And patients are advised to report the use of any other prescription or over-the-counter medications or herbal products to their physician.

Advise patients not to take oral doses of Orladeyo in excess of 150 mg once daily or additional doses of Orladeyo capsules to treat hereditary angioedema HAE acute attacks due to the risk of QT prolongation.

  Patients who are allergic to any of the ingredients in Berostat capsule Orladeyo should not use this drug for treatment.

The above is the introduction about Orladeyo. If patients have other questions about Orladeyo (such as drug prices, purchase channels, etc.), they can consult the medical companion travel service.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.